{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T14:31:29Z","timestamp":1778509889067,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T00:00:00Z","timestamp":1773014400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s11307-026-02093-w","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T15:40:34Z","timestamp":1773070834000},"page":"280-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Malignant Pleural Mesothelioma (MPM) Evaluation with [11C]-Methionine PET\/CT Before and After Talc Pleurodesis"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-1094","authenticated-orcid":false,"given":"Egesta","family":"Lopci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Castello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Testori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuele","family":"Voulaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daoud","family":"Rahal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Perrino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Crepaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio Maria","family":"Ferraroli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Errico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Bottoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcello","family":"Rodari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Muraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Marulli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Alloisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo Andrea","family":"Zucali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2093_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s11864-008-0067-z","volume":"9","author":"H Yang","year":"2008","unstructured":"Yang H, Testa JR, Carbone M (2008) Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol 9:147\u2013157","journal-title":"Curr Treat Options Oncol"},{"key":"2093_CR2","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S0022-5223(99)70469-1","volume":"117","author":"DJ Sugarbaker","year":"1999","unstructured":"Sugarbaker DJ, Flores RM, Jaklitsch MT, Richards WG, Strauss GM, Corson JM et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54\u201365","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2093_CR3","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/resp.12328","volume":"19","author":"R Thomas","year":"2014","unstructured":"Thomas R, Francis R, Davies HE, Lee YC (2014) Interventional therapies for malignant pleural effusions: the present and the future. Respirology 19:809\u2013822","journal-title":"Respirology"},{"issue":"1","key":"2093_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0022-5223(03)00207-1","volume":"126","author":"RM Flores","year":"2003","unstructured":"Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW (2003) Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 126(1):11\u201316","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2093_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1007\/s00259-010-1704-x","volume":"38","author":"VH Gerbaudo","year":"2011","unstructured":"Gerbaudo VH, Mamede M, Trotman-Dickenson B, Hatabu H, Sugarbaker DJ (2011) FDG PET\/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Eur J Nucl Med Mol Imaging 38:810\u2013821","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2093_CR6","doi-asserted-by":"publisher","first-page":"4587","DOI":"10.1200\/JCO.2006.06.8999","volume":"24","author":"GL Ceresoli","year":"2006","unstructured":"Ceresoli GL, Chiti A, Zucali PA, Rodari M, Lutman RF, Salamina S et al (2006) Early response evaluation in malignant pleural mesothelioma by positron emission tomography with [18F]fluorodeoxyglucose. J Clin Oncol 24:4587\u201393","journal-title":"J Clin Oncol"},{"key":"2093_CR7","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1158\/1078-0432.CCR-09-2313","volume":"16","author":"AK Nowak","year":"2010","unstructured":"Nowak AK, Francis RJ, Phillips MJ, Millward MJ, van der Schaaf AA, Boucek J et al (2010) A Novel prognostic model for malignant mesothelioma incorporating quantitative FDG-PET imaging and clinical parameters. Clin Cancer Res 16:2409\u20132417","journal-title":"Clin Cancer Res"},{"key":"2093_CR8","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1053\/j.semnuclmed.2025.01.003","volume":"55","author":"E Lopci","year":"2025","unstructured":"Lopci E (2025) Current status of staging and restaging malignant pleural mesothelioma. Semin Nucl Med 55:240\u2013251","journal-title":"Semin Nucl Med"},{"key":"2093_CR9","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1378\/chest.125.6.2356","volume":"125","author":"BH Kwek","year":"2004","unstructured":"Kwek BH, Aquino SL, Fischman AJ (2004) Fluorodeoxyglucose positron emission tomography and CT after talc pleurodesis. Chest 125:2356\u20132360","journal-title":"Chest"},{"key":"2093_CR10","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1097\/01.rlu.0000089522.86184.49","volume":"28","author":"N Weiss","year":"2003","unstructured":"Weiss N, Solomon SB (2003) Talc pleurodesis mimics pleural metastases: differentiation with positron emission tomography\/computed tomography. Clin Nucl Med 28:811\u2013814","journal-title":"Clin Nucl Med"},{"key":"2093_CR11","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1097\/RLU.0b013e3181bece11","volume":"34","author":"NC Nguyen","year":"2009","unstructured":"Nguyen NC, Tran I, Hueser CN, Oliver D, Farghaly HR, Osman MM (2009) F-18 FDG PET\/CT characterization of talc pleurodesis-induced pleural changes over time: a retrospective study. Clin Nucl Med 34:886\u2013890","journal-title":"Clin Nucl Med"},{"key":"2093_CR12","first-page":"432","volume":"42","author":"PL Jager","year":"2001","unstructured":"Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA (2001) Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42:432\u201345","journal-title":"J Nucl Med"},{"key":"2093_CR13","first-page":"4075","volume":"31","author":"K Kaira","year":"2011","unstructured":"Kaira K, Oriuchi N, Takahashi T, Nakagawa K, Ohde Y, Okumura T et al (2011) L-type amino acid transporter 1 (LAT1) expression in malignant pleural mesothelioma. Anticancer Res 31:4075\u20134082","journal-title":"Anticancer Res"},{"key":"2093_CR14","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1056\/NEJMc071823","volume":"357","author":"GL Ceresoli","year":"2007","unstructured":"Ceresoli GL, Chiti A, Santoro A (2007) 11C-labeled methionine and evaluation of malignant pleural mesothelioma. N Engl J Med 357:1982\u20131984","journal-title":"N Engl J Med"},{"issue":"3","key":"2093_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000356752","volume":"87","author":"T Vandemoortele","year":"2014","unstructured":"Vandemoortele T, Laroumagne S, Roca E, Bylicki O, Dales JP, Dutau H, Astoul P (2014) Positive FDG-PET\/CT of the pleura twenty years after talc pleurodesis: three cases of benign talcoma. Respiration 87(3):243\u2013248","journal-title":"Respiration"},{"issue":"11","key":"2093_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.arbres.2017.04.008","volume":"53","author":"L Gorospe Saras\u00faa","year":"2017","unstructured":"Gorospe Saras\u00faa L, Jover-D\u00edaz R, Arrieta P (2017) Intense pleural FDG uptake 12 years after talc pleurodesis: PET\/CT findings. Arch Bronconeumol 53(11):638","journal-title":"Arch Bronconeumol"},{"key":"2093_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2021.153660","volume":"228","author":"A Soltermann","year":"2021","unstructured":"Soltermann A, Opitz I, Burger IA (2021) Histology of the pleural rind at [18F]FDG PET\/CT hot and cold spots in mesothelioma patients after talc pleurodesis and neoadjuvant chemotherapy. Pathol Res Pract 228:153660","journal-title":"Pathol Res Pract"},{"issue":"6","key":"2093_CR18","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1053\/j.semnuclmed.2022.07.005","volume":"52","author":"E Lopci","year":"2022","unstructured":"Lopci E, Castello A, Mansi L (2022) FDG PET\/CT for staging and restaging malignant mesothelioma. Semin Nucl Med 52(6):806\u2013815","journal-title":"Semin Nucl Med"},{"key":"2093_CR19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1097\/MNM.0000000000001078","volume":"40","author":"E Lopci","year":"2019","unstructured":"Lopci E, Novellis P, Testori A, Rahal D, Voulaz E, Bottoni E et al (2019) In-vivo imaging of methionine metabolism in patients with suspected malignant pleural mesothelioma. Nucl Med Commun 40:1179\u20131186","journal-title":"Nucl Med Commun"},{"issue":"9","key":"2093_CR20","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s12149-013-0750-4","volume":"27","author":"R Nishii","year":"2013","unstructured":"Nishii R, Higashi T, Kagawa S, Kishibe Y, Takahashi M, Yamauchi H et al (2013) Diagnostic usefulness of an amino acid tracer, \u03b1-[N-methyl-(11)C]-methylaminoisobutyric acid ( (11)C-MeAIB), in the PET diagnosis of chest malignancies. Ann Nucl Med 27(9):808\u201321","journal-title":"Ann Nucl Med"},{"issue":"6","key":"2093_CR21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s12149-007-0142-8","volume":"22","author":"HJ Hsieh","year":"2008","unstructured":"Hsieh HJ, Lin SH, Lin KH, Lee CY, Chang CP, Wang SJ (2008) The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules\/masses when compared with 18F-FDG-PET. Ann Nucl Med 22(6):533\u2013538","journal-title":"Ann Nucl Med"},{"issue":"8","key":"2093_CR22","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.2967\/jnumed.112.103069","volume":"53","author":"P Wiriyasermkul","year":"2012","unstructured":"Wiriyasermkul P, Nagamori S, Tominaga H, Oriuchi N, Kaira K, Nakao H et al (2012) Transport of 3-fluoro-L-\u03b1-methyl-tyrosine by tumor-upregulated L-type amino acid transporter 1: a cause of the tumor uptake in PET. J Nucl Med 53(8):1253\u201361","journal-title":"J Nucl Med"},{"issue":"1","key":"2093_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/1754-9485.13592","volume":"68","author":"IJ May","year":"2024","unstructured":"May IJ, Nowak AK, Francis RJ, Ebert MA, Dhaliwal SS (2024) The prognostic value of F18 fluorothymidine positron emission tomography for assessing the response of malignant pleural mesothelioma to chemotherapy - a prospective cohort study. J Med Imaging Radiat Oncol 68(1):57\u201366","journal-title":"J Med Imaging Radiat Oncol"},{"key":"2093_CR24","first-page":"127","volume":"8","author":"M Bonomi","year":"2017","unstructured":"Bonomi M, De Filippis C, Lopci E, Gianoncelli L, Rizzardi G, Cerchiaro E et al (2017) Clinical staging of malignant pleural mesothelioma: current perspectives. Lung Cancer (Auckl) 8:127\u2013139","journal-title":"Lung Cancer (Auckl)"},{"key":"2093_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1053\/j.semnuclmed.2021.04.002","volume":"51","author":"E Lopci","year":"2021","unstructured":"Lopci E, Kobe C, Gnanasegaran G, Adam JA, de Geus-Oei LF (2021) PET\/CT variants and pitfalls in lung cancer and mesothelioma. Semin Nucl Med 51:458\u2013473","journal-title":"Semin Nucl Med"},{"key":"2093_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/s00259-014-2960-y","volume":"42","author":"E Lopci","year":"2015","unstructured":"Lopci E, Zucali PA, Ceresoli GL, Perrino M, Giordano L, Gianoncelli L et al (2015) Quantitative analyses at baseline and interim PET evaluation for response assessment and outcome definition in patients with malignant pleural mesothelioma. Eur J Nucl Med Mol Imaging 42:667\u201375","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2093_CR27","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG (2015) Introduction to the 2015 World Health Organization classification of tumours of the lung, pleura, thymus, and heart. J Thorac Oncol 10:1240\u20131242","journal-title":"J Thorac Oncol"},{"key":"2093_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","volume":"11","author":"F Galateau-Salle","year":"2016","unstructured":"Galateau-Salle F, Churg A, Roggli V, Travis WD, World Health Organization Committee for Tumours of the Pleura (2016) The 2015 World Health Organization classification of tumours of the pleura: advances since the 2004 classification. J Thorac Oncol 11:142\u201354","journal-title":"J Thorac Oncol"},{"key":"2093_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-5-27","volume":"5","author":"N Barbetakis","year":"2010","unstructured":"Barbetakis N, Asteriou C, Papadopoulou F, Samanidis G, Paliouras D, Kleontas A et al (2010) Early and late morbidity and mortality and life expectancy following thoracoscopic talc insufflation for control of malignant pleural effusions: a review of 400 cases. J Cardiothorac Surg 5:27","journal-title":"J Cardiothorac Surg"},{"key":"2093_CR30","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1148\/rg.336125105","volume":"33","author":"GA Ulaner","year":"2013","unstructured":"Ulaner GA, Lyall A (2013) Identifying and distinguishing treatment effects and complications from malignancy at FDG PET\/CT. Radiographics 33:1817\u20131834","journal-title":"Radiographics"},{"key":"2093_CR31","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1016\/j.clinimag.2013.06.009","volume":"37","author":"A Niccoli-Asabella","year":"2013","unstructured":"Niccoli-Asabella A, Notaristefano A, Rubini D, Altini C, Ferrari C, Merenda N et al (2013) 18F-FDG PET\/CT in suspected recurrences of epithelial malignant pleural mesothelioma in asbestos-fibers-exposed patients (comparison to standard diagnostic follow-up). Clin Imaging 37:1098\u20131103","journal-title":"Clin Imaging"},{"key":"2093_CR32","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1245\/s10434-010-1107-z","volume":"17","author":"HY Lee","year":"2010","unstructured":"Lee HY, Hyun SH, Lee KS, Kim BT, Kim J, Shim YM et al (2010) Volume-based parameter of 18F-FDG PET\/CT in malignant pleural mesothelioma: prediction of therapeutic response and prognostic implications. Ann Surg Oncol 17:2787\u20132794","journal-title":"Ann Surg Oncol"},{"key":"2093_CR33","first-page":"1233","volume":"17","author":"A Abakay","year":"2013","unstructured":"Abakay A, Komek H, Abakay O, Palanci Y, Ekici F, Tekbas G et al (2013) Relationship between 18FDG PET-CT findings and the survival of 177 patients with malignant pleural mesothelioma. Eur Rev Med Pharmacol Sci 17:1233\u20131241","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2093_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00259-013-2561-1","volume":"41","author":"A Klabatsa","year":"2014","unstructured":"Klabatsa A, Chicklore S, Barrington SF, Goh V, Lang-Lazdunski L, Cook GJ (2014) The association of 18F-FDG PET\/CT parameters with survival in malignant pleural mesothelioma. Eur J Nucl Med Mol Imaging 41:276\u2013282","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2093_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.lungcan.2009.04.015","volume":"67","author":"P Veit-Haibach","year":"2010","unstructured":"Veit-Haibach P, Schaefer NG, Steinert HC, Soyka JD, Seifert B, Stahel RA (2010) Combined FDG-PET\/CT in response evaluation of malignant pleural mesothelioma. Lung Cancer 67:311\u2013317","journal-title":"Lung Cancer"},{"key":"2093_CR36","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.2967\/jnumed.107.042333","volume":"48","author":"RJ Francis","year":"2007","unstructured":"Francis RJ, Byrne MJ, van Der Schaaf AA, Boucke JA, Nowak AK, Phillips M et al (2007) Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semi-automated 3- dimensional volume \u2013 based analysis of serial 18F-FDG PET scans. J Nucl Med 48:1449\u20131458","journal-title":"J Nucl Med"},{"key":"2093_CR37","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1111\/resp.13252","volume":"23","author":"J Leemans","year":"2018","unstructured":"Leemans J, Dooms C, Ninane V, Yserbyt J (2018) Success rate of medical thoracoscopy and talc pleurodesis in malignant pleurisy: a single-centre experience. Respirology 23:613\u2013617","journal-title":"Respirology"},{"key":"2093_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.7150\/jca.2586","volume":"3","author":"G Genestreti","year":"2012","unstructured":"Genestreti G, Moretti A, Piciucchi S, Giovannini N, Galassi R, Scarpi E et al (2012) FDG PET\/CT response evaluation in malignant pleural mesothelioma patients treated with talc pleurodesis and chemotherapy. J Cancer 3:241\u20135","journal-title":"J Cancer"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-026-02093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-026-02093-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-026-02093-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T13:37:30Z","timestamp":1778506650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-026-02093-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2093"],"URL":"https:\/\/doi.org\/10.1007\/s11307-026-02093-w","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institutional review board of IRCCS Humanitas Research Hospital (IRB No. 1287), and written consent was required and obtained for all participants in the study. All procedures performed in studies involving human participants were in accordance with the Helsinki Declaration as revised in 2024 and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Written informed consent has been obtained before inclusion in the study from all patients or legal representatives of the patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they did not use any type of generative AI in the writing of this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI in Scientific Writing"}},{"value":"Egesta Lopci, Angelo Castello, Alberto Testori, Emanuele Voulaz, Daoud Rahal, Matteo Perrino, Alessandro Crepaldi, Giorgio Maria Ferraroli, Edoardo Bottoni, Valentina Errico, Marcello Rodari, Lorenzo Muraglia, Giuseppe Marulli, Marco Alloisio, and Paolo Andrea Zucali declare that they have no conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}